+ Equity
Scientific R&D software
Open for applications
+ Equity
501-1000 employees
To accelerate scientific innovation in order to make the world a healthier, cleaner, and safer place to live.
Jump to section
To accelerate scientific innovation in order to make the world a healthier, cleaner, and safer place to live.
Scientific breakthroughs require collaboration in research efforts, but the challenge of obtaining and using meaningful scientific data is generally a major choke point, delaying and even derailing projects that could otherwise have yielded major discoveries. Dotmatics was founded to solve this problem, providing a collaborative R&D platform that could keep up with the evolving data challenges facing research teams.
Dotmatics' platform connects and organizes disparate sources of scientific data for use in research work, and supplements this with a range of applications to allow for collaboration, reporting and improved workflows. Its solution is used by more than two million researchers worldwide and has been adopted by major firms such as Merck, Bristol Myers Squibb and Moderna.
Dotmatics is constantly improving its platform, forming partnerships and making strategic acquisitions to add further capabilities to its portfolio of services. It is currently focusing on developing the user experience of the platform, increasing the unification of its scientific tools with its core package, and improving its data processing and organising capabilities.
Steph
Company Specialist at Welcome to the Jungle
Dec 2021
$95m
LATE VC
This company has top investors
Thomas Swalla
(CEO, not founder)Previously served as CEO at GraphPad, Student Brands, and Duel Commerce.
Design
Sales & Account Management